Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Marketable Securities: ¥157 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688076 Sinopep Allsino Bio Pharmaceutical Co Ltd SHSE:688076
75 GF Score
Price ¥26.89
GF Value ¥60.58
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Sinopep Allsino Bio Pharmaceutical Co Marketable Securities?

Sinopep Allsino Bio Pharmaceutical Co SHSE:688076 -2.22% 75 Marketable Securities is ¥157 Mil as of Mar. 2026. GuruFocus rates SHSE:688076 with a GF Score™ of 75/100 and a GF Value™ of ¥60.58 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sinopep Allsino Bio Pharmaceutical Co's Marketable Securities for the quarter that ended in Mar. 2026 was ¥157 Mil.

Sinopep Allsino Bio Pharmaceutical Co's annual Marketable Securities increased from Dec. 2023 (¥0 Mil) to Dec. 2024 (¥208 Mil) but then declined from Dec. 2024 (¥208 Mil) to Dec. 2025 (¥116 Mil).

Sinopep Allsino Bio Pharmaceutical Co  (SHSE:688076) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sinopep Allsino Bio Pharmaceutical Co Marketable Securities Related Terms

Sinopep Allsino Bio Pharmaceutical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Sinopep Allsino Bio Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopep Allsino Bio Pharmaceutical Co Marketable Securities Chart

Sinopep Allsino Bio Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.13 43.01 0.00 208.00 116.00

Sinopep Allsino Bio Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 93.50 93.00 116.00 156.91
SHSE:688076
75GF Score
Sinopep Allsino Bio Pharmaceutical Co Ltd SHSE:688076
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinopep Allsino Bio Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥157 Mil mean?
Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) has a Marketable Securities of ¥157 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors.
Is Sinopep Allsino Bio Pharmaceutical Co's Marketable Securities too high?
Sinopep Allsino Bio Pharmaceutical Co's current Marketable Securities is ¥157 Mil. Overall, Sinopep Allsino Bio Pharmaceutical Co has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopep Allsino Bio Pharmaceutical Co's Marketable Securities compare to VRTX and REGN?
Sinopep Allsino Bio Pharmaceutical Co's Marketable Securities of ¥157 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors. Sinopep Allsino Bio Pharmaceutical Co's current Marketable Securities is ¥157 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopep Allsino Bio Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥60.58, compared to a current price of ¥26.89 — trading 55.6% below its estimated fair value. The current Marketable Securities is ¥157 Mil. Sinopep Allsino Bio Pharmaceutical Co's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076), the current Marketable Securities is ¥157 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥26.89 is trading 55.6% below its estimated GF Value™ of ¥60.58. GuruFocus considers Sinopep Allsino Bio Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:688076:

  • Marketable Securities: ¥157 Mil
  • GF Value™: ¥60.58 vs. price of ¥26.89 (55.6% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinopep Allsino Bio Pharmaceutical Co Business Description

Address No. 28, Linpu Road, Economic and Technological Development Zone, Jiangsu Province, Lianyungang, CHN, 222069
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
75GF Score

Get the complete analysis for SHSE:688076

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.89
Price
¥60.58
GF Value